Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Saved in:
Bibliographic Details
Title: Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Authors: Oporto Espuelas M; Infection, Immunity and Inflammation, UCL Great Ormond Ormond Street Institute of Child Health, London, UK. m.oporto@ucl.ac.uk., Burridge S; Department of Haematology, Great Ormond Street Hospital, London, UK., Kirkwood AA; Cancer Research UK & Cancer Trials Centre, UCL, London, UK., Bonney D; Department of Blood and Bone Marrow Transplant, Royal Manchester Children's Hospital, Manchester, UK., Watts K; Department of Blood and Bone Marrow Transplant, Royal Manchester Children's Hospital, Manchester, UK., Shenton G; Great North Children's Hospital, Newcastle upon Tyne, UK., Jalowiec KA; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., O'Reilly MA; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Roddie C; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Castleton A; Department of Haematology, The Christie Hospital NHS Foundation Trust, Manchester, UK., Clesham K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Nicholson E; Department of Haematology/Bone Marrow Transplantation, The Royal Marsden NHS Foundation Trust, London, UK.; Institute of Cancer Research, London, UK., Alajangi R; Department of Haematology/Bone Marrow Transplant, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Prabhu S; Department of Haematology/Bone Marrow Transplant, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., George L; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK., Uttenthal B; Cambridge University Hospital NHS Foundation Trust, Cambridge, UK., Gabelli M; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK.; Pediatric Onco-hematology and Hematopoietic Stem Cell Transplantation, Woman and Child Health Department, University of Padova, Padua, Italy., Neill L; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Besley C; Department of Haematology/Bone Marrow Transplant, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Chaganti S; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK., Wynn RF; Department of Blood and Bone Marrow Transplant, Royal Manchester Children's Hospital, Manchester, UK., Bartram J; Department of Haematology, Great Ormond Street Hospital, London, UK., Chiesa R; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK., Lucchini G; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK., Pavasovic V; Department of Haematology, Great Ormond Street Hospital, London, UK., Rao A; Department of Haematology, Great Ormond Street Hospital, London, UK., Rao K; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK., Silva J; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK., Samarasinghe S; Department of Haematology, Great Ormond Street Hospital, London, UK., Vora A; Department of Haematology, Great Ormond Street Hospital, London, UK., Clark P; NHS England, London, UK., Cummins M; Bristol Royal Hospital for Children, Bristol, UK., Marks DI; Department of Haematology, University Hospitals Bristol, Bristol, UK., Amrolia P; Infection, Immunity and Inflammation, UCL Great Ormond Ormond Street Institute of Child Health, London, UK.; Department of Bone Marrow Transplant, Great Ormond Street Hospital, London, UK., Hough R; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Ghorashian S; Department of Haematology, Great Ormond Street Hospital, London, UK.; Developmental Biology and Cancer, UCL Great Ormond Ormond Street Institute of Child Health, London, UK.
Source: Blood cancer journal [Blood Cancer J] 2024 Apr 15; Vol. 14 (1), pp. 66. Date of Electronic Publication: 2024 Apr 15.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2044-5385
DOI:10.1038/s41408-024-01038-2